EPIQ Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.38M Sell
8,980
-40
-0.4% -$10.6K 1.02% 28
2026
Q2
$2.29M Sell
9,020
-240
-3% -$55.9K 0.97% 30
2026
Q1
$2.26M Hold
9,260
– – 1.06% 28
2025
Q4
$1.92M Hold
9,260
– – 0.89% 32
2025
Q3
$1.72M Hold
9,260
– – 0.81% 35
2025
Q2
$1.41M Hold
9,260
– – 0.72% 36
2025
Q1
$1.54M Buy
9,260
+1
+0% +$156 0.81% 36
2024
Q4
$1.34M Hold
9,259
– – 0.72% 35
2024
Q3
$1.5M Sell
9,259
-11,865
-56% -$1.89M 0.83% 32
2024
Q2
$3.09M Buy
21,124
+1,283
+6% +$191K 2.09% 22
2024
Q1
$3.14M Sell
19,841
-448
-2% -$71.3K 2.09% 20
2023
Q4
$3.18M Buy
20,289
+370
+2% +$56.7K 2.28% 17
2023
Q3
$3.1M Buy
19,919
+6
+0% +$990 2.34% 14
2023
Q2
$3.3M Buy
19,913
+330
+2% +$53.3K 2.24% 18
2023
Q1
$3.04M Buy
19,583
+1,770
+10% +$286K 2.09% 19
2022
Q4
$3.15M Sell
17,813
-952
-5% -$164K 2.09% 18
2022
Q3
$3.06M Buy
18,765
+1,070
+6% +$181K 1.9% 20
2022
Q2
$3.14M Buy
17,695
+2,776
+19% +$495K 1.92% 20
2022
Q1
$2.64M Buy
14,919
+520
+4% +$88.5K 1.42% 28
2021
Q4
$2.46M Buy
14,399
+369
+3% +$60.4K 1.31% 29
2021
Q3
$2.27M Buy
14,030
+2,700
+24% +$461K 1.04% 39
2021
Q2
$1.87M Buy
11,330
+232
+2% +$38.4K 0.94% 41
2021
Q1
$1.82M Buy
11,098
+880
+9% +$142K 1.04% 37
2020
Q4
$1.61M Buy
10,218
+1,197
+13% +$177K 1.12% 36
2020
Q3
$1.3M Sell
9,021
-260
-3% -$38.5K 0.98% 38
2020
Q2
$1.3M Hold
9,281
– – 1.19% 36
2020
Q1
$1.22M Buy
9,281
+229
+3% +$32.5K 1.35% 32
2019
Q4
$1.32M Buy
+9,052
New +$1.23M 1.34% 33

Other funds holding JNJ

EPIQ Partners's JNJ Position: Q3 2026 in Review

EPIQ Partners reduced its Johnson & Johnson (JNJ) stake by 0.44% in Q3 2026, selling an estimated $10.6K and leaving 8,980 shares worth $2.38M. The position accounts for 1.02% of the portfolio, ranked #28.

EPIQ Partners first reported a position in JNJ in Q4 2019 and has held it in 28 quarters since. The position peaked at $3.3M in Q2 2023. 1,611 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • EPIQ Partners held 8,980 shares of Johnson & Johnson worth $2.38M as of Q3 2026.
  • EPIQ Partners sold 40 Johnson & Johnson shares in Q3 2026, an estimated $10.6K.
  • Johnson & Johnson made up 1.02% of EPIQ Partners's portfolio in Q3 2026, its #28 holding.
  • EPIQ Partners first reported a position in Johnson & Johnson in Q4 2019 and has held it in 28 quarters since.
  • EPIQ Partners's Johnson & Johnson position peaked at $3.3M in Q2 2023.
  • 1,611 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on EPIQ Partners's 13F filing for Q3 2026, filed 7 Oct 2026.